Neo Pharma Private Limited

Develops real estate projects since 1950, based in Mumbai, Maharashtra.

1950 | Mumbai, Maharashtra (India) | Active
Last Updated:

Neo Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.09 Cr
  • Paid Up Capital ₹ 6.02 M
  • Company Age 74 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 5,122.31 Cr
  • Satisfied Charges ₹ 1,283.00 Cr
  • Revenue Growth -35.62%
  • Profit Growth -53.30%
  • Ebitda -51.82%
  • Net Worth 3.86%
  • Total Assets 7.40%

About Neo Pharma

Neo Pharma Private Limited (NPPL) was founded in India on 09 March 1950 and has a glorious history of 74 years and 11 months. Its registered office is in Mumbai, Maharashtra, India.

The Corporate was formerly known as Neo Pharma Limited. The Company is engaged in the Real Estate And Construction Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.09 Cr and a paid-up capital of Rs 6.02 M.

The company currently has active open charges totaling ₹5,122.31 Cr. The company has closed loans amounting to ₹1,283.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Jayant Oswal, Venkatesh Bhandare, and Bajrang Bararia serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24239MH1950PTC008016

  • Company No.

    008016

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    09 Mar 1950

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Real Estate and Construction

Who are the key members and board of directors at Neo Pharma?

Board Members (3)

NameDesignationAppointment DateStatus
Jayant Oswal Country flag representing In Director 28-Mar-2015Current
Venkatesh Bhandare Country flag representing In Director 30-Nov-2017Current
Bajrang Bararia Country flag representing In Director 12-Mar-2021Current

Financial Performance of Neo Pharma.

Neo Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 35.62% decrease. The company also saw a substantial fall in profitability, with a 53.3% decrease in profit. The company's net worth moved up by a moderate rise of 3.86%.

Neo Pharma revenue growth over time
Neo Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-35.62%
Revenue from Operations
-59.11%
Total Assets
7.40%
Profit or Loss
-53.30%
Net Worth
3.86%
EBITDA
-51.82%

What is the Ownership and Shareholding Structure of Neo Pharma?

In 2023, Neo Pharma had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹5,122.31 Cr

Satisfied Charges

₹1,283.00 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 4572.31 Cr
  • Others : 550.00 Cr

Latest Charge Details

DateLenderAmountStatus
30 Sep 2024Others₹55.00 CrOpen
30 Apr 2021Hdfc Bank Limited₹4,572.31 CrOpen
31 Mar 2021Others₹175.00 CrOpen
23 Oct 2019Others₹95.00 CrOpen
14 Feb 2018Others₹225.00 CrOpen

How Many Employees Work at Neo Pharma?

Neo Pharma has a workforce of 43 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Neo Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neo Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Neo Pharma

Recent activity within the organization

  • Charges

    A charge registered on 11 Nov 2020 via Charge ID 100392779 with Others was fully satisfied on 11 Nov 2024.

  • Charges

    A charge registered on 11 Nov 2020 via Charge ID 100392780 with Others was fully satisfied on 11 Nov 2024.

  • Charges

    A charge with Others amounted to Rs. 55.00 Cr with Charge ID 101003869 was registered on 30 Sep 2024.

  • Annual General Meeting

    Neo Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 4,572.31 Cr registered on 30 Apr 2021 with Charge ID 100446535 was modified on 30 Jun 2023.

  • Charges

    A charge registered on 22 Apr 2022 via Charge ID 100567580 with Others was fully satisfied on 27 Jun 2023.

Frequently asked questions

  • What is the Incorporation or founding date of Neo Pharma Private Limited?

    Neo Pharma Private Limited was incorporated on 09 Mar 1950.

  • What is authorized share capital and paid-up capital of Neo Pharma Private Limited?

    The authorized share capital of Neo Pharma Private Limited is ₹ 1.09 Cr and paid-up capital is ₹ 6.02 M.

  • Who are the current board members & directors of Neo Pharma Private Limited?

    Currently 3 directors are associated with Neo Pharma Private Limited.

    • Jayant Chaganlal Oswal
    • Venkatesh Gajanan Bhandare
    • Bajrang Lal Bararia

  • What is the registered address of Neo Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Neo Pharma Private Limited is Kasturi Buildingj Tata Road India, Mumbai, Maharashtra, 400020.

  • What is the corporate identification number (CIN) and company number of Neo Pharma Private Limited?

    The corporate identification number (CIN) of Neo Pharma Private Limited is U24239MH1950PTC008016 and the company number is 008016 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Neo Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Neo Pharma Private Limited has fallen by -35.62%.

  • How many employees does Neo Pharma Private Limited currently have?

    As Per 2023 financial reports, 43 employees are currently employed by Neo Pharma Private Limited.

  • What change has been observed in the net worth of Neo Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Neo Pharma Private Limited has experienced an upsurge of 3.86%.

  • What are the total open charges for Neo Pharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Neo Pharma Private Limited amount to ₹ 5,122.31 Cr.

  • When was the last Balance Sheet of Neo Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Neo Pharma Private Limited was filed with the ROC on 31 Mar 2023.

People also Viewed

Similar Companies Based on Real Estate Builders & Developers